ML44719, a Phase II, Open-label, Multi-cohort, Multicenter Study in Patients with Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis Read more about ML44719, a Phase II, Open-label, Multi-cohort, Multicenter Study in Patients with Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis
A Two-cohort, Phase Ii, Multicenter, Randomized, Double-bliind, Parallel-group, Placebo-controlled Study Evaluating the Efficacy and Safety of Vixarelimab Compared With Placebo in Patients With Read more about A Two-cohort, Phase Ii, Multicenter, Randomized, Double-bliind, Parallel-group, Placebo-controlled Study Evaluating the Efficacy and Safety of Vixarelimab Compared With Placebo in Patients With
A Randomized, Double-blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizu Read more about A Randomized, Double-blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizu
A Phase 2, Randomized, Placebo-controlled, Parallel Group, Multicenter 12-week Study with a 52-week Extension to Evaluate the Efficacy and Safety of Two Doses of K-808 (Pemafibrate) in Subjects with P Read more about A Phase 2, Randomized, Placebo-controlled, Parallel Group, Multicenter 12-week Study with a 52-week Extension to Evaluate the Efficacy and Safety of Two Doses of K-808 (Pemafibrate) in Subjects with P
Transspinal Magnetic Stimulation for the Treatment of Neuropathic Pain Read more about Transspinal Magnetic Stimulation for the Treatment of Neuropathic Pain
Serum Markers of Glucagon Sensitivity in Calorie Restricted Humans Read more about Serum Markers of Glucagon Sensitivity in Calorie Restricted Humans
Inner Ear Ion Channels in Healthy and Diseased Conditions Read more about Inner Ear Ion Channels in Healthy and Diseased Conditions
Development of a subcutaneous cell pharmacy implant Read more about Development of a subcutaneous cell pharmacy implant
